GRF — EAGLE CAPITAL GROWTH FUND, INC.
—
NYSE ·
Unknown ·
Unknown ·
CIK 850027 ·
Last close
$10.15
Market Cap
$40.27M
52W High
$11.85
52W Low
$9.50
ADV30
3,344
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 48,359,376 | — | 33,122 |
| Dec 2025 | — | — | — | — | 47,500,636 | — | 64,690 |
| Jun 2025 | — | — | — | — | 47,802,512 | — | 69,914 |
Balance + Analyst (yfinance extras)
Retained Earnings
$24,765,919
Inventory
—
Receivables
$60,383
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$901,549
EBITDA
—
Free Cash Flow
—
Enterprise Value
—
Total Cash
—
Total Debt
$0
Shares Out
3,967,836
Trailing EPS
$1.00
Book Value
$12.18
ROE
8.3%
ROA
0.4%
Div Yield
8.16%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,284,764 | — | 5,028,583 | 47,500,636 | 64,690 | 47,435,946 | — |
| Dec 2024 | 5,800,501 | — | 5,540,862 | 45,843,132 | 63,108 | 45,780,024 | — |
| Dec 2023 | 4,853,149 | — | 4,612,434 | 43,002,015 | 64,726 | 42,937,289 | — |
| Dec 2022 | -1,561,908 | — | -1,805,909 | 39,777,755 | 64,157 | 39,713,598 | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VMXXF | VALHALLA METALS INC. | $40.20M | $0.27 | — |
| NKGFF | Nevada King Gold Corp. | $40.15M | $0.40 | — |
| PEW | GrabAGun Digital Holdings Inc. | $40.54M | $1.37 | — |
| IZEA | IZEA Worldwide, Inc. | $39.94M | $2.31 | — |
| TGLO | THEGLOBE COM INC | $39.73M | $0.09 | — |
News headlines (Yahoo Finance, 1h cache)
Eagle Capital Growth Fund Declares Year-End Distribution of $0.49 Per Share
2026-11-13 21:49 · Yahoo
Grifols (BME:GRF) Starts Phase 3 Trials As Undervalued Narrative Faces A Fresh Test
2026-07-28 17:09 · Yahoo
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
2026-07-16 12:00 · Yahoo
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
2026-06-15 12:00 · Yahoo
Grifols (BME:GRF) Valuation Check After Mixed Short And Long Term Share Price Performance
2026-05-10 00:23 · Yahoo
Green Rise Announces Certain Management Changes
2026-01-05 22:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.